Relate Inc

HIV PREVENTION, CARE AND TREATMENT SUPPORT FOR CHURCH RELATED HOSPITALS AND CLINICS IN THE REPUBLIC OF ZIMBABWE UNDER THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR)

COORDINATING ALL RESOURCES EFFECTIVELY (CARE) FOR CHILDREN WITH MEDICAL COMPLEXITY

THE NATIONAL HEALTHY BRAIN INITIATIVE: DEVELOP AND ADVANCE IMPLEMENTATION OF PUBLIC HEALTH STRATEGIES

CENTER FOR DEMENTIA RESPITE INNOVATION

LIBBY, MONTANA'S PUBLIC HEALTH EMERGENCY: ASBESTOS HEALTH SCREENING

PPHF-13-LIBBY MONTANA'S PUBLIC HEALTH EMERGENCY: ASBESTOS HEALTH SCREENING

LIBBY, MONTANA PUBLIC HEALTH EMERGENCY: ASBESTOS HEALTH SCREENING

THE ALZHEIMERS ASSOCIATION WILL, THROUGHOUT THIS FIVE-YEAR PROJECT, EXPAND AND MAINTAIN THE NATIONAL ALZHEIMERS CALL CENTER (NACC) TO BETTER SERVE PEOPLE LIVING WITH ALZHEIMERS DISEASE AND RELATED

THE ALZHEIMER'S ASSOCIATION WILL, THROUGHOUT THIS FIVE-YEAR PROJECT, EXPAND AND MAINTAIN THE NATIONAL ALZHEIMER'S CALL CENTER (NACC) TO BETTER SERVE PEOPLE LIVING WITH ALZHEIMER'S DISEASE AND RELATED

CENTER FOR ASBESTOS RELATED DISEASE ASBESTOS HEALTH SCREENING PROGRAM - LIBBY, MONTANA WAS THE SITE OF VERMICULITE MINING AND PROCESSING OPERATIONS FROM THE EARLY 1920’S THROUGH 1990 AND, AT PEAK PRODUCTION, WAS THE WORLD’S LARGEST SOURCE OF VERMICULITE. COMMERCIAL USES OF VERMICULITE INCLUDE INSULATION, FIREPROOFING, AND USE AS A SOIL CONDITIONER. AMONG RESIDENTS, VERMICULITE WAS DISTRIBUTED FREELY AND USED EXTENSIVELY IN LAWNS, DRIVEWAYS, AND GARDENS, AS WELL AS IN MANY HOUSES AND COMMERCIAL BUILDINGS AS INSULATION. THERE WERE VERMICULITE PROCESSING AND BAGGING FACILITIES IN DOWNTOWN LIBBY WHERE PILES OF ORE WERE ACCESSIBLE FOR CHILDREN TO PLAY IN ADJACENT TO THE LOCAL BASEBALL FIELDS. HIGH LEVELS OF DUST IN THE AMBIENT AIR DUE TO MINING AND PROCESSING OPERATIONS WERE ALSO DOCUMENTED. UNFORTUNATELY, LIBBY’S VERMICULITE ORE IS CONTAMINATED WITH AMPHIBOLE ASBESTOS. REPORTS OF PERVASIVE ASBESTOS-RELATED HEALTH OUTCOMES IN LIBBY LED TO EPA AND ATSDR INVESTIGATIONS. ATSDR SCREENED OVER 7,000 PEOPLE FROM 2000-2001 AND FOUND THAT APPROXIMATELY 17% HAD ASBESTOS RELATED ABNORMALITIES ON CHEST X-RAYS. SINCE THEN, THE STATE OF MONTANA CONDUCTED SCREENING PROGRAMS FROM 2000-2008 FOLLOWED BY LINCOLN COUNTY FROM 2009-2011. THE CENTER FOR ASBESTOS RELATED DISEASE (CARD) HAS CONDUCTED SCREENINGS FROM 2001- PRESENT FUNDED BY PREVIOUS ITERATIONS OF THIS GRANT. THE PURPOSE OF THE PROPOSED PROGRAM IS TO CONTINUE TO (1) PROVIDE MEDICAL SCREENING TO PERSONS WITH POSSIBLE EXPOSURE TO LA THAT OCCURRED IN LINCOLN COUNTY, MONTANA; (2) CONDUCT NATIONWIDE OUTREACH TO RAISE AWARENESS OF THE SCREENING PROGRAM AMONG PERSONS ELIGIBLE TO PARTICIPATE AS WELL AS OF THE AVAILABILITY OF CERTAIN MEDICARE BENEFITS; (3) PROVIDE HEALTH EDUCATION TO MULTIPLE AUDIENCES TO DETECT, PREVENT, AND TREAT ENVIRONMENTAL HEALTH CONDITIONS RELATED TO LA EXPOSURE. THE THREE COMPONENTS OF THIS PROJECT WILL BE CONDUCTED CONCURRENTLY IN AN INTEGRATED MANNER BOTH LOCALLY AND NATIONWIDE WITH NO GAP IN PROGRAM IMPLEMENTATION BETWEEN THE CURRENT GRANT PERIOD AND THE NEW GRANT PERIOD. SCREENING SERVICES FOR ARD SCREENING AND LCS WILL CONTINUE AS DESCRIBED IN REPORTS FOR THE PREVIOUS VERSIONS OF THIS GRANT. QUALITY CONTROL PROCESSES WILL CONTINUE AS CURRENTLY ESTABLISHED, WHILE OUTREACH AND EDUCATION ACTIVITIES WILL ALSO REMAIN SIMILAR AS NOTED IN MORE DETAIL BELOW. SHORT-TERM AND INTERMEDIATE OUTCOMES ARE EXPECTED TO BE ACCOMPLISHED WITHIN THE PROJECT PERIOD WHILE LONG-TERM OUTCOMES ARE ANTICIPATED AS LONG-TERM RESULTS OF PROJECT ACTIVITIES AND MAY NOT BE MEASURABLE DURING THE PROJECT PERIOD. THE TARGET POPULATIONS, AS SPECIFIED IN THE ACA LEGISLATION, ARE INDIVIDUALS AT RISK FOR ENVIRONMENTAL HEALTH CONDITIONS, BOTH MALIGNANT AND NON-MALIGNANT ASBESTOS RELATED DISEASES (ARD), DUE TO POSSIBLE EXPOSURE TO AMPHIBOLE ASBESTOS OCCURRING IN THE LIBBY AREA. AN AT-RISK INDIVIDUAL WILL BE DEFINED AS HAVING BEEN PRESENT FOR A SUM OF AT LEAST 6 MONTHS IN THE AREA SUBJECT TO AN EMERGENCY DECLARATION, LINCOLN COUNTY, MONTANA. THE SIX MONTHS MUST HAVE BEEN AT LEAST TEN YEARS AGO DUE TO THE EXTENDED LATENCY PERIOD FOR DEVELOPING ARD FOLLOWING EXPOSURE. SPECIFIC SHORT-TERM AND INTERMEDIATE OUTCOMES ARE AS FOLLOWS: SHORT-TERM OUTCOMES: INCREASED AWARENESS OF SCREENING SERVICES AND INCREASED AWARENESS OF MEDICARE ELIGIBILITY (OUTREACH), INCREASED ENROLLMENT IN MEDICARE FOR INDIVIDUALS WITH COVERED DIAGNOSES (SCREENING), INCREASED KNOWLEDGE ABOUT EXPOSURE PREVENTION, RISKS OF SMOKING, ASBESTOS-RELATED DISEASE, AND DISEASE MANAGEMENT AMONG THE TARGET COMMUNITY AND PHYSICIANS (EDUCATION). INTERMEDIATE OUTCOMES: INCREASED ENROLLMENT IN DISEASE MANAGEMENT PROGRAMS (OUTREACH), INCREASED AWARENESS OF SMOKING REDUCTION/ CESSATION PROGRAMS IN THE TARGET POPULATION (SCREENING), INCREASED REFERRALS FOR TREATMENT FOR ASBESTOS-RELATED CANCERS (SCREENING), IMPROVED TREATMENT/ MANAGEMENT OF INDIVIDUALS WITH ASBESTOS-RELATED DISEASE (EDUCATION), DECREASED RATE OF SMOKING (EDUCATION/SCREENING), REDUCTION IN ASBESTOS EXPOSURE (EDUCATION), INCREASED CONTINUITY OF SCREENING AMONG PREVIOUS

RURAL HEALTH CARE SERVICES OUTREACH GRANT PROGRAM

ALZHEIMER'S ASSOCIATION NATIONAL CONTACT CENTER

EXPANSION OF HIV/AIDS CARE AND PREVENTION

DEMENTIA RISK REDUCTION PUBLIC HEALTH CENTER OF EXCELLENCE

THE HEALTHY BRAIN INITIATIVE: IMPLEMENTING PUBLIC HEALTH ACTIONS RELATED TO COGNITIVE HEALTH, COGNITIVE IMPAIRMENT, AND CAREGIVING AT THE STATE AND L

GH13-1330, ZIMBABWE: EXPANSION OF HIV/AIDS CARE AND PREVENTION

A COOPERATIVE AGREEMENT TO PARTNER AND IMPLEMENT PUBLIC HEALTH STRATEGIES RELATED

ALZHEIMER'S ASSOCIATION CALL CENTER

LIBBY, MONTANA PUBLIC HEALTH EMERGENCY: ASBESTOS HEALTH SCREENING

NATIONAL ALZHEIMER'S CALL CENTER

ALZHEIMER'S ASSOCIATION TO PARTNER AND IMPLEMENT PUBLIC HEALTH STRATEGIES

EXPANSION OF HIV/AIDS CARE AND PREVENTION ACTIVITIES AMONG CHURCH RELATED HOSPITA

LINC-AD: LEVERAGING AN INTERDISCIPLINARY CONSORTIUM TO IMPROVE CARE AND OUTCOMES FOR PERSONS LIVING WITH ALZHEIMER'S AND DEMENTIA

ALZHEIMER'S ASSOCIATION WANDERING AND SAFETY RESPONSE INITATIVE

CARINGKIND CONNECTS: IMPROVING DEMENTIA CAPABILITY FOR PEOPLE, PROGRAMS AND PROFESSIONALS

ALZHEIMER'S ASSOCIATION SAFE RETURN PROGRAM

ALZHEIMER'S ASSOCIATION INTERDISCIPLINARY SUMMER RESEARCH INSTITUTE (AA-ISRI) ON ALZHEIMER'S DISEASE AND RELATED DEMENTIAS

ALZHEIMER'S ASSOCIATION - GREATER MICHIGAN CHAPTER DEMENTIA AND DISABILITIES SUPPORTIVE SERVICES PROGRAM

STRENGTHENING THE FINANCIAL LITERACY & PREPAREDNESS OF FAMILY CAREGIVERS

HEALTH CARE AND OTHER FACILITIES

VIRTUAL REALITY FACILITATION OF RECOVERY FROM OPIOID USE DISORDER - PROJECT SUMMARY / ABSTRACT THIS PHASE I PROJECT IS A PILOT RANDOMIZED CLINICAL TRIAL DESIGNED TO SHOW COMMERCIAL POTENTIAL FOR A NOVEL VIRTUAL REALITY INTERVENTION IN PREPARATION FOR PHASE II DEVELOPMENT. WE PROPOSE TESTING OUR ADJUNCTIVE INTERVENTION FOR EFFICACY ON REDUCING OPIOID USE AND INCREASING ABSTINENCE IN EARLY RECOVERING OPIOID USE DISORDER (OUD) PERSONS, WITH CONCOMITANT INCREASES IN SELF-REPORTED AND BEHAVIORAL FOCUS ON FUTURE OUTCOMES. IMPAIRED FUTURE ORIENTATION IS A HALLMARK OF OUD AND OTHER ADDICTIONS. WITH RECOVERY ATTEMPTS USUALLY FAILING WITHIN 6 MONTHS OF TREATMENT, THERE IS CONSIDERABLE ROOM FOR IMPROVED EFFICACY. CONVERGING EVIDENCE, INCLUDING OUR PRELIMINARY DATA, INDICATES THAT INCREASING VISUALIZATION OF THE FUTURE SHOULD IMPROVE RECOVERY OUTCOMES. OUR PILOT TESTING OF THE INTERVENTION WAS PROMISING, WITH N=14 OUT OF N=18 PARTICIPANTS REMAINING ABSTINENT 30 DAYS LATER; IMPORTANTLY, 10 OF THE 14 ABSTAINERS SHOWED A POSITIVE RESPONSE TO THE INTERVENTION, I.E., 100% OF RESPONDERS REMAINED ABSTINENT—SUGGESTING AN EFFICACY MARKER. THE VR INTERVENTION INCREASED FUTURE SELF-IDENTIFICATION AND DELAY-OF-REWARD IN PEOPLE RECOVERING FROM SUBSTANCE USE DISORDER AND ENGAGED BRAIN NETWORKS GOVERNING PROSPECTION. FURTHER, THE VR EFFECT ON DELAY-OF-REWARD CORRELATED WITH INTROSPECTIVE-EXECUTIVE BRAIN CONNECTIVITY. EXTENDING PRIOR WORK ON EPISODIC FUTURE THINKING, WE EMPLOYED A PERSONALIZED, IMMERSIVE VIRTUAL EXPERIENCE THAT INTEGRATES PERSONAL DETAILS AND MAXIMIZES SENSORY ENGAGEMENT. OUR INTERVENTION INCREASES CONNECTEDNESS WITH ONE’S FUTURE THROUGH A REALISTIC INTERACTION WITH FUTURE SELVES IN DIVERGING FUTURES RESULTING FROM DIFFERENT CHOICES. IMPORTANTLY, WE INTEGRATE SELF-DISCREPANCY THEORY, FOCUSING ON THE STARK CONTRAST BETWEEN THESE FUTURES TO HEIGHTEN IMPACT, AND WE PROMOTE ENGAGEMENT BY MAXIMIZING THE NOVELTY AND EMOTIONAL SALIENCE OF THE EXPERIENCE. PARTICIPANTS IN EARLY RECOVERY ENTER A REALISTIC VIRTUAL WORLD, ARE INTRODUCED TO A TIME TRAVEL NARRATIVE, AND INTERACT WITH TWO DIGITALLY AGE-PROGRESSED FUTURE SELVES; ONE AFTER 15 YEARS OF ONGOING OPIOID ABUSE, AND THE OTHER AFTER 15 YEARS OF RECOVERY. FUTURE SELVES SPEAK TO THE PARTICIPANT ABOUT THEIR RECOVERY REWARDS, OR LOSSES FROM RETURNING TO HABITUAL DRUG USE, AND PERSONAL STRUGGLES DURING THE JOURNEY. STRONG EMPHASIS IS PLACED ON AGENCY, OPTIMISM, AND DECISION-MAKING. AFTER ITERATIVE DEVELOPMENT AND TESTS OF FEASIBILITY AND SAFETY, THE PARADIGM YIELDED A PROMISING EFFICACY SIGNAL, BEHAVIORAL CHANGE, AND BRAIN TARGET ENGAGEMENT. THE CURRENT PROPOSAL WILL VALIDATE THIS PARADIGM IN AN EXPANDED AND MORE HOMOGENOUS OUD SAMPLE TO SHOW EFFICACY AND BEHAVIORAL MECHANISMS USING THE SAME VR PARADIGM. AIM 1 WILL TEST FOR EFFICACY ON OPIOID USE OUTCOMES (DAYS OF USE AND ABSTINENCE) WITH LONGITUDINAL ASSESSMENTS AT 30 DAYS. AIM 2 WILL DETERMINE MECHANISMS BY TESTING FOR CHANGES IN FUTURE SELF-IDENTIFICATION, FUTURE ORIENTATION, AND BEHAVIORAL DELAY DISCOUNTING. SUCCESSFUL VALIDATION IN PHASE I WILL ENABLE TRANSITION INTO A PHASE II COMMERCIALIZATION APPLICATION, WITH THE GOAL OF CREATING A MARKETABLE, AFFORDABLE, USER-FRIENDLY SOFTWARE PRODUCT FOR FACILITATING BETTER RECOVERY OUTCOMES IN CLINICAL SETTINGS.

VALUE- ADDED AGRICULTURAL PRODUCT MARKET DEVELOPMENT GRANTS

VALUE- ADDED AGRICULTURAL PRODUCT MARKET DEVELOPMENT GRANTS

DESIGNATED HEALTH PROJECTS

ALZHEIMER'S ASSOCIATION WANDERING AND SAFETY RESPONSE INITIATIVE

EPIDEMIOLOGY REPOSITORY ON TREMOLITE ASBESTOS

2009 CONGRESSIONAL MANDATES: NON-NORC

HEALTH CARE AND OTHER FACILITIES

EARLY-ONSET ALZHEIMER?S AND OTHER DEMENTIA: FROM NATURAL HISTORY TO CLINICAL TRIALS - PROJECT SUMMARY APPROXIMATELY 5.8 MILLION AMERICANS AGE 65 AND OLDER HAVE ALZHEIMER'S DISEASE, AND THIS NUMBER IS EXPECTED TO INCREASE TO 13.8 MILLION BY 2050. WHILE MOST DEVELOP DIAGNOSABLE SYMPTOMS AT OR OVER THE AGE OF 65 (E.G. LATE-ONSET), 5-10% DEVELOP SYMPTOMS AT AGE 64 OR YOUNGER AND ARE CLASSIFIED AS EARLY-ONSET. EARLY- AND LATE- ONSET ALZHEIMER'S DISEASE SHARE THE SAME PATHOLOGIC SUBSTRATE, BUT THERE ARE CRITICAL DIFFERENCES IN THEIR CLINICAL PRESENTATIONS, BIOLOGICAL PHENOTYPES, AND LIFE IMPACT. MOREOVER, EARLY-ONSET DEMENTIA IS MORE LIKELY THAN LATE- ONSET DEMENTIA TO BE CAUSED BY PATHOLOGIES OTHER THAN ALZHEIMER'S, INCLUDING VASCULAR, LEWY BODY, AND FRONTOTEMPORAL DEGENERATION. BECAUSE OF THEIR YOUNG AGE AND ATYPICAL SYMPTOMS, EARLY-ONSET PATIENTS OFTEN FACE A SIGNIFICANT DELAY TO DIAGNOSIS. DEMENTIA ONSET AT SUCH A YOUNG AGE ALSO HAS DISPROPORTIONATELY DEVASTATING FINANCIAL AND EMOTIONAL CONSEQUENCES FOR PATIENTS, FAMILIES, AND SOCIETY. DUE TO AGE RESTRICTIONS OR ABSENCE OF MEMORY DEFICITS, EARLY-ONSET PATIENTS ARE UNDER-REPRESENTED IN ONGOING LARGESCALE GENOME AND OBSERVATIONAL BIOMARKER STUDIES AND IN THERAPEUTIC TRIALS. TO DATE, NO LARGE-SCALE CLINICAL TRIALS HAVE SPECIFICALLY ADDRESSED EARLY-ONSET MCI AND DEMENTIA. THE ALZHEIMER'S ASSOCIATION (AA) PROPOSES TO CREATE AND IMPLEMENT A TWO-DAY CONFERENCE, TO BE HELD ANNUALLY FOR 3 YEARS, ENTITLED EARLY-ONSET ALZHEIMER'S AND OTHER DEMENTIA: FROM NATURAL HISTORY TO CLINICAL TRIALS. PATIENTS, CARERS, AND FAMILY MEMBERS WILL BE INVOLVED IN THE PLANNING, IMPLEMENTATION, AND EVALUATION COMPONENTS OF THE CONFERENCE. THE SHORT-TERM GOAL OF THE CONFERENCE IS TO CREATE A FORUM FOR DISCUSSION OF RESEARCH, TRIAL DESIGN, DRUG DEVELOPMENT, AND OTHER CONCERNS AMONG KEY STAKEHOLDERS. THE LONG-TERM GOAL IS TO INCREASE THE LIKELIHOOD, QUALITY AND PATIENT-CENTEREDNESS OF FUTURE CLINICAL TRIALS ADDRESSING EARLY-ONSET MCI AND DEMENTIA. A CONFERENCE WORKGROUP MADE UP OF THE PI AND COLLABORATORS, ADDITIONAL LEADING EXPERTS IN DEMENTIA, AND INDIVIDUALS WITH EARLY-ONSET MCI OR DEMENTIA AND/OR THEIR FAMILY MEMBERS WILL DEVELOP, IMPLEMENT, AND OVERSEE ALL CONFERENCE, EVALUATION, AND DISSEMINATION ACTIVITIES. THE CONFERENCES WILL BE HELD IN COORDINATION WITH THE ANNUAL ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) AND OFFER DIDACTIC, PANEL DISCUSSION, AND POSTER BASED FORMATS, AS WELL AS FACE-TO-FACE NETWORKING OPPORTUNITIES, ANTICIPATING 250 ATTENDEES. LUNCH POSTER SESSIONS DEDICATED TO THE EARLY CAREER INVESTIGATORS WILL BE HELD ON BOTH DAYS OF THE CONFERENCE, AND MULTIPLE APPROACHES WILL BE USED TO ENSURE DIVERSITY AMONGST SPEAKERS AND ATTENDEES. DISSEMINATION EFFORTS WILL INCLUDE WEBINARS, PRESS RELEASES, SOCIAL MEDIA HIGHLIGHTS, AND MANUSCRIPTS DOCUMENTING CONFERENCE PROCEEDINGS AND FINDINGS.

OLDER DRIVER RESOURCES ON CAREGIVERS AND DEMENTIA

PROMOTING DIVERSE PERSPECTIVES: ADDRESSING HEALTH DISPARITIES RELATED TO ALZHEIMER'S AND OTHER DEMENTIAS - PROJECT SUMMARY ALZHEIMER'S AND OTHER DEMENTIAS ARE PRIMARY CAUSES OF DISABILITY AND DEPENDENCY IN THE US, BUT DO NOT AFFECT ALL GROUPS EQUALLY. AFRICAN AMERICANS, AMERICAN INDIANS/ALASKA NATIVES, AND HISPANIC/LATINO AMERICANS HAVE HIGHER RISK OF DEMENTIA THAN NON-LATINO WHITES AND ASIAN AMERICANS. RESEARCH TO UNDERSTAND AND AMELIORATE HEALTH DISPARITIES SHOULD BE A PUBLIC HEALTH PRIORITY, BUT HISTORICALLY FEW AGING-RELATED RESEARCH GRANT AWARDS RELATE TO HEALTH DISPARITIES. IN RESPONSE, THE NIA CREATED THE HEALTH DISPARITIES RESEARCH FRAMEWORK (HDRF), WHICH HIGHLIGHTS ENVIRONMENTAL, SOCIOCULTURAL, BEHAVIORAL, AND BIOLOGICAL FACTORS THAT CONTRIBUTE TO DISPARITIES IN AGE-RELATED DISEASE. TO ADVANCE DISPARITIES RESEARCH IN DEMENTIA SPECIFICALLY, THE ALZHEIMER'S ASSOCIATION (AA) WILL DEVELOP AND HOLD TWO 2-DAY CONFERENCES, OCCURRING IN CONSECUTIVE YEARS (2021-22), FOR WHICH ALL KEYNOTE, PLENARY, POSTER AND OTHER PRESENTATIONS WILL BE MAPPED ONTO THE NIA HDFR. OBJECTIVES INCLUDE: 1) INCREASE COLLABORATION ACROSS THE SCIENTIFIC COMMUNITY, 2) PROMOTE DIFFUSION OF NEW RESEARCH DESIGNS AND ANALYTIC METHODS, 3) CREATE INFORMATION AND MENTORING BRIDGES BETWEEN SENIOR AND EARLY CAREER INVESTIGATORS, AND 4) PROMOTE MORE SYSTEMATIC RESEARCH VIA THE NIA HDRF. EACH 250 IN-PERSON AND 150 REMOTELY-CONNECTED CONFERENCE WILL BE HELD IN WASHINGTON, DC. CONFERENCE ATTENDANCE WILL BE FREE, AND TRAVEL AND MEALS WILL BE COVERED FOR SPEAKERS AND CONFERENCE WORKGROUP MEMBERS. THE AA WILL COVER EXPENSES RELATING TO PERSONNEL, CONFERENCE MEALS, THE PROFESSIONAL NETWORKING RECEPTION, AND BASIC SUPPLIES. TO MEET OUR OBJECTIVES, THE FIVE AIMS ARE: 1) FINALIZE THE SCIENTIFIC PROGRAM AND ALL LOGISTICAL DETAILS FOR THE CONFERENCE, VIA THE CONFERENCE WORKGROUP THAT DEVELOPED THE PRELIMINARY PROGRAM. THE CONFERENCE WORKGROUP CONSISTS OF A DIVERSE GROUP OF AA AND NON-AA EXPERTS AND IS LED BY PRINCIPAL INVESTIGATOR, DR. CARL V. HILL OF AA. 2), IMPLEMENT THE CONFERENCES, ENTITLED “PROMOTING DIVERSE PERSPECTIVES BY ADDRESSING HEALTH DISPARITIES RELATED TO ALZHEIMER'S AND OTHER DEMENTIAS”, CONSISTING OF LECTURES, PANELS, POSTER SESSIONS, NETWORKING OPPORTUNITIES, AND ONLINE EVALUATION OF THE CONFERENCES. 3), FACILITATE SUSTAINABILITY OF THESE EFFORTS BY HOSTING TWO MID-YEAR WEBINARS, HIGHLIGHTING DEVELOPMENTS IN THE FIELD. 4), PROMOTE THE CAREERS OF EARLY INVESTIGATORS VIA DEDICATED POSTER SESSIONS, MENTORING/SHORT PRESENTATION SESSIONS, AND MONTHLY SOCIAL MEDIA, “SPOTLIGHTS.” 5), DISSEMINATE CONFERENCE FINDINGS AND PROMOTE FUTURE RESEARCH BY PUBLISHING CONFERENCE PROCEEDINGS AND SPECIAL ISSUES IN RELEVANT JOURNALS FEATURING RESEARCH DERIVED FROM THE CONFERENCES AND WEBINARS. RESULTS WILL INCLUDE 1) DISSEMINATION OF MULTI-LEVEL ANALYSES OF DETERMINANTS OF DISPARITIES IN ALZHEIMER'S AND OTHER DEMENTIAS; 2) NEW CROSS-DISCIPLINARY FERTILIZATION, NETWORKING AND COLLABORATIONS IN DISPARITIES RESEARCH IN DEMENTIA; 3) CAREER ENHANCEMENT FOR EARLY CAREER INVESTIGATORS AND 4) OVERALL ADVANCEMENT OF DEMENTIA SCIENCE TOWARD THE DISCOVERY OF NEW MITIGATING AND TREATMENT APPROACHES FOR ALL PEOPLE.

ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) ADVANCEMENTS: TOWARDS HEALTH EQUITY IN ALZHEIMER’S ANDALL OTHER DEMENTIAS - PROJECT SUMMARY DEMENTIA IS THE PRIMARY CAUSE OF DISABILITY AND DEPENDENCY WORLDWIDE. IN THE UNITED STATES, MINORITIZED POPULATIONS - INCLUDING AFRICAN AMERICANS, AMERICAN INDIANS/ALASKA NATIVES AND HISPANIC/LATINO INDIVIDUALS - ARE MORE LIKELY TO DEVELOP DEMENTIA THAN NON-LATINO WHITES AND ASIAN AMERICANS. THERE IS A PAUCITY OF DATA ON THE IMPACT OF LIFECOURSE, BIOLOGICAL AND STRUCTURAL FACTORS ON DEMENTIA RISK IN THESE UNDERSERVED POPULATIONS. THIS IS IN PART DUE TO THE HISTORIC EXCLUSION OF THESE POPULATIONS FROM RESEARCH INTO ADRDS. THE PROPOSED CONFERENCE WILL BRING TOGETHER ESTABLISHED AND EARLY CAREER RESEARCHERS TO EXAMINE THESE EXISTING DISPARITIES THROUGH A HEALTH EQUITY LENS. TO CATALYZE VITAL CONVERSATIONS ON THE TOPIC OF DISPARITIES IN ADRDS, THE ALZHEIMER’S ASSOCIATION HOSTED THE FIRST 2 PROMOTING DIVERSE PERSPECTIVES: ADDRESSING HEALTH DISPARITIES RELATED TO ALZHEIMER’S AND ALL DEMENTIAS CONFERENCES IN 2021 AND 2022. BUILDING ON THE SUCCESS OF THOSE 2 CONFERENCES, THE ALZHEIMER’S ASSOCIATION IS PROPOSING THREE CONFERENCES AND TWO WORKSHOPS SPREAD OVER A FIVE-YEAR PERIOD UNDER THE NAME, AAIC ADVANCEMENTS: TOWARDS HEALTH EQUITY IN ADRD. THE CONFERENCES WILL TYPICALLY BE TWO DAYS AND THE WORKSHOPS WILL TAKE PLACE IN CONJUNCTION WITH THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCES HELD IN THE UNITED STATES. AT THE CORE OF THE CONFERENCE WILL STILL BE THE NIA HDR. TO MEET OUR OBJECTIVES, THE FIVE AIMS ARE: 1) DEVELOP AND FINALIZE THE SCIENTIFIC PROGRAM AND ALL LOGISTICAL DETAILS FOR THE CONFERENCE BY WORKING WITH A DIVERSE GROUP OF EXPERTS LED BY PI DR. MARIA CARRILLO. 2) IMPLEMENT THREE CONFERENCES AND WORKSHOPS OVER A FIVE-YEAR PERIOD ENTITLED “AAIC ADVANCEMENTS: TOWARD HEALTH EQUITY IN ADRD”, WHICH WILL CONSIST OF LECTURES, PLENARY PRESENTATIONS, PANELS, POSTER SESSIONS, NETWORKING OPPORTUNITIES AND FEEDBACK ON THE CONFERENCE. 3) FACILITATE THE SUSTAINABILITY OF THE CONFERENCES BY HOSTING WORKSHOPS ON THE OFF YEARS IN CONJUNCTION WITH AAIC. 4) INCORPORATE THE PERSPECTIVES OF EARLY CAREER RESEARCHERS BY ENSURING THAT THEY ARE INCLUDED ON THE PLANNING COMMITTEES TO ASSIST US IN IDENTIFYING BARRIERS TO PARTICIPATION AND RETENTION OF THESE SCHOLARS IN THE ADRD FIELD. 5) DISSEMINATE THE PROCEEDINGS OF THE CONFERENCE IN PEER REVIEWED JOURNALS WHICH WILL HELP KEEP A RECORD OF THE ADVANCEMENTS BEING MADE IN THE FIELD BUT ALSO INFORM FUTURE EFFORTS TO HELP THE FIELD MOVE CLOSER TO HEALTH EQUITY. RESULTS FROM THIS CONFERENCE WILL INCLUDE 1) DISSEMINATION OF IDEAS FOR PROJECTS USING EXISTING DATASETS FOR HEALTH EQUITY RESEARCH IN ADRD 2) INCREASED COLLABORATION BETWEEN EARLY CAREER AND MORE ESTABLISHED INVESTIGATORS 3) SKILLS TRAINING IN THE METHODS REQUIRED TO DO HEALTH EQUITY RESEARCH IN ADRD 4) AWARENESS OF BARRIERS FACED BY EARLY CAREER RESEARCH TO FUNDING AGENCIES AND DECISION MAKERS.

JOUBERT SYNDROME BIENNIAL CONFERENCE: ADVANCING TRANSLATIONAL CILIOPATHY RESEARCH

EXPLORING RESEARCH COMMUNICATION AND ENGAGEMENT IN A RURAL COMMUNITY: THE LIBBY P

FRONTIERS IN ICHTHYOSIS RESEARCH

IMMUNODEFICIENCIES AND AUTOIMMUNE DISEASES (A SCIENTIFIC COLLOQUIUM)

(DO NOT USE)ALZHEIMER'S ASSOCIATION CONTACT CENTER

SOUTHERN CALIFORNIA COLLABORATIVE TO SUPPORT INDIVIDUALS, FAMILIES AND COMMUNITIES IMPACTED BY ALZHEIMER'S DISEASE

ASSISTANCE TO FIREFIGHTERS GRANT

ASSISTANCE TO FIREFIGHTERS GRANT